Post-azacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms Meeting Abstract


Authors: Nannya, Y.; Tobiasson, M.; Sato, S.; Bernard, E.; Ohtake, S.; Takeda, J.; Creignou, M.; Kusakabe, M.; Shibata, Y.; Nakamura, N.; Watanabe, M.; Hiramoto, N.; Shiozawa, Y.; Shiraishi, Y.; Tanaka, H.; Yoshida, K.; Kakicuchi, N.; Makishima, H.; Nakagawa, M.; Usuki, K.; Watanabe, M.; Imada, K.; Handa, H.; Taguchi, M.; Kiguchi, T.; Ohyashiki, K.; Ishikawa, T.; Takaori, A.; Tsurumi, H.; Kasahara, S.; Chiba, S.; Naoe, T.; Miyano, S.; Papaemmanuil, E.; Miyazaki, Y.; Hellstrom-Lindberg, E.; Ogawa, S.
Abstract Title: Post-azacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
Meeting Title: 17th International Congress on Myelodysplastic Syndromes (MDS)
Journal Title: Leukemia Research
Volume: 128
Issue: Suppl.
Meeting Dates: 2023 May 3-6
Meeting Location: Marseille, France
ISSN: 0145-2126
Publisher: Elsevier Ltd  
Date Published: 2023-05-01
Start Page: 107124
Language: English
ACCESSION: WOS:000995928100047
DOI: 10.1016/j.leukres.2023.107124
PROVIDER: wos
Notes: Meeting Abstract: O11 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Elsa Bernard
    49 Bernard